GenScript, a biotechnology company, has announced the commercial launch of its neoantigen peptide synthesis service for biotech and pharma companies developing personalized cancer therapeutics. The ...

GenScript now offers fast-track cGMP neoantigen peptide and peptide active pharmaceutical ingredients (API) from its new life-sciences manufacturing facility in Zhenjiang, leveraging its long history ...

GenScript is delighted to announce its 4th Annual Virtual Summit on Gene and Cell Engineering. This event will feature leading experts from academia, pharma, and biotech, showcasing the transformative ...

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography ...

GenScript is best known for its gene synthesis capabilities, which we estimate is more than half of the life science services and products segment. In 2014, GenScript was the leader in gene synthesis, ...

GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK) receives the “Best Contract Research Organization Award” on the 4th Annual Asia Pacific Bioprocessing Excellence Awards Ceremony 2021 ...